Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
38 participants
OBSERVATIONAL
2008-02-29
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis:
1. Pain does not correlate with changes in the PD morphology suggesting that pain in CP is not only a mechanical problem
2. Pain in CP correlates better with the levels of NGF in the pancreatic juice. NGF is variably expressed in different morphological stages of CP and regulates the sensitivity of the peptidergic nociceptors and is upregulated in pancreatic inflammation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A PiLot ClinicaL TrIal of ParicAlcitol for ChroNiC PancrEatitis
NCT05664880
Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis
NCT01717599
Early Enteral Nutrition for Severe Acute Pancreatitis
NCT00995098
Regular vs. Clear Liquid Diet for Mild to Moderate Acute Pancreatitis
NCT04932785
Determinants of Depression and Its Impact on Quality of Life in Patients With Chronic Pancreatitis
NCT04867304
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic pancreatitis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Any comorbid condition with expected survival \< 1 year.
* Patients with pacemaker, implanted metallic prosthesis or other contraindications to do MRCP.
* Patients \< 18 years of age at time of consent
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bimaljit S Sandhu, M.D
Role: PRINCIPAL_INVESTIGATOR
Associate Professor, VCU Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Commonwealth University Medical Center
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HM11033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.